The evolution of HIV/AIDS Epidemic in Romania 31 December 2013

Size: px
Start display at page:

Download "The evolution of HIV/AIDS Epidemic in Romania 31 December 2013"

Transcription

1 The evolution of HIV/AIDS Epidemic in Romania 31 December 2013

2 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS Data and further processed and elaborated by Compartment for Monitoring and Evaluation of HIV/AIDS data in Romania, in National Institute for Infectious Diseases Prof. Dr. Matei Bals

3 Romania December 2013: PLWHA ( cumulative total, since 1985). High rate of HIV incidence in children who were infected in the 1980s in Romania The maximum number of these patients recorded at the beginning of the 1990s ; >90%: sub-type F1. During the same period, HIV incidence rate among the adult population was low, with a slight increase afterwards due to unprotected heterosexual contact, the main route of transmission for the last decade. Currently, Romania has a large number of survivors in the age group, who belong to the cohort (>6000). A large number of PLWHA who receive specific ARV therapy in relation to the total number of infected persons (>8000 December 31, 2012 out of 9800 in active surveillance at1 December 2013). Source: Surveillance Report: HIV/AIDS Surveillance in Europe ECDC Stockholm Source: Compartment for Monitoring and Evaluation of HIV/AIDS Data in Romania INBI Prof.Dr.M.Balş

4

5

6 HIV subtype: F predominance, unique in Europe cohort children: homogenous F1 subtype of HIV Thomson and Najera, JID, 2007; Stanojevic et al. AIDS Rev 2011;

7 Phylogenetic analysis of HIV-1 subtype F1 isolates F= <1% HIV infections worldwide: Africa & South America Romanian F1 subtype: closely related to Angolan subtype distantly related to S America F1 F1 origin: Congo (DRC), around the late 1950s Guimaraes & al Retrovirology 2009

8 Ministry of Health National Institute for Infectious Diseases Prof. Dr. Matei Bals Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania General Data at 31 December 2013 TOTAL HIV/AIDS (CUMULATIVE ) OF WHICH: HIV/AIDS cases in children (0-14 years at date of diagnosis ) HIV/AIDS cases in adults (> 14 years at date of diagnosis) Total no. of AIDS deaths ( ) Out of records HIV/AIDS children + adults 621 Number of patients living with HIV/AIDS Total AIDS (Cumulative ) AIDS cases in children (0-14 years at date of diagnosis) AIDS cases in adults (> 14 years at date of diagnosis) Total HIV (Cumulative ) HIV cases in children (0-14 years at date of diagnosis) HIV cases in adults (> 14 years at date of diagnosis) New HIV/AIDS cases, diagnosed in New HIV cases 472 New AIDS cases 325 HIV/AIDS related deaths, confirmed by medical charts in

9 Distribution of ages Age at date of diagnosis Cumulative total Distribution by age of PLWHA

10 Kaplan-Meyer survival curve % of persons who deceased, survived, on average >50 months: 15% of persons who deceased survived, on average around 100 month; 10% of persons who deceased survived, on average, 100 months. Limitations: we excluded the periods with no treatment, ART schemes, duration of treatment. Average period of survival= 43,4 months (C.I.95% 42,1-44,6) Median period of survival for men=42,2 months (C.I.95% 40,6-43,8) Median period of survival for women=45,4 months (C.I.95% 43-47,2)

11 New HIV/AIDS Cases 1 JANUARY 31 DECEMBER 2013

12 Distribution of new HIV/AIDS cases by counties LEGEND CHILDREN (0-14 yrs) ADULTS (> 14 yrs)

13 Distribution of new HIV/AIDS cases by sex, 2013

14 Distribution of new HIV/AIDS cases by age group and sex, 2013

15 Distribution of new HIV/AIDS cases by route of transmission in children, Vertical Male female

16 Distribution of new HIV/AIDS cases by routes of transmission in adults, 2013

17 Tendencies in routes of transmission Romania Route of transmission 31 December December December December December December December 2013 Vertical 8 (2%) 7 (1%) 20 (4%) 25 (5%) 21 (3%) 21 (2,6%) 21 (2,64%) MSM IDU 14 (3%) 40 (8%) 44 (9%) 60 (11) 95 (13%) 89 (10,8%) 4 (1%) 3 (1%) 7 (1,4%) 14 (3%) 131 (18%) MSM/IDU 1 (<0,5%) 5 (1%) Heterosexual 352 (79%) 397 (76) 383 (77%) 399 (75%) 440 (61%) Unknown 67 (15%) 71 (14%) 43 (8,6%) 32 (6%) 28 (4%) 252 (30,6%) 6 (1%) 414 (50%) 39 (5%) 88 (11,04%) 233 (29,23%) 5 (0,63%) 435 (54,58%) 15 (1,88%) Total

18 Tendencies in the routes of transmission Romania Heterosexual IDUs

19 New HIV/AIDS cases (January-December 2013) through i.v. drug use, by age groups Age group Male Female Total yrs yrs yrs yrs yrs yrs Total

20 New cases of HIV/AIDS infection through i.v. drug use, by age groups, recorded in % 6% 2% 7% 15% 30% 29% yrs yrs yrs yrs yrs yrs. 50

21 Drugs used by HIV patients, diagnosed in 2013

22 Drugs declared by HIV/IDU patients, diagnosed in % 10% 3% 69% Heroine Heroine/Ethnobotanicals/Cocaine Heroine/Ethnobotanicals Ethnobotanicals

23 New HIV/AIDS cases (January-December 2013) through i.v. drug use, by counties County Male Female Total Arad 1 1 Argeş 1 1 Bucureşti Braşov 1 1 Brăila 1 1 Buzau 1 1 Constanţa 3 3 Giurgiu 1 1 Gorj 1 1 Hunedoara 1 1 Ialomita 4 4 Ilfov Mureş 1 1 Neamţ 2 2 Olt 1 1 Prahova Timiş 3 3 Tulcea 1 1 Vâlcea 2 2 Total

24 HBV, HCV, STDs in new HIV/AIDS cases through i.v. drug use Tested for Positive % AgHBs 3 1,24% VHC % AgHBs + VHC 29 12,03% STDs 34 14,10%

25 HIV/TB Co-infection in HIV/IDUs, diagnosed in 2013

26 I.V. drug users diagnosed HIV+ in 2013, previously tested before the current HIV positive test Year of previous testing No. of patients Total 53

27 New HIV/AIDS cases registered in the National Data Base: vs. New HIV/AIDS cases in IDUs registered in the National Data Base: Year Criterion Number of HIV cases TOTAL of which IDUs TOTAL of which IDUs TOTAL of which IDUs TOTAL of which IDUs TOTAL of which IDUs Number of AIDS cases Total number of HIV/AIDS cases

28 HIV prevalence in IDUs under treatment HIV/HCV Prevalence in IDUs under treatment HCV prevalence in IDUs under treatment Source: The evolution of the HIV/AIDS outbreak among IDUs in Romania. Andrei Botescu- Romanian National Antidrug Agency

29 HIV testing in IDUs performed by the Public Health Directions Year Negative tests Positive tests TOTAL % positive tests % % % % % % %

30 CD4 values in new HIV/AIDS cases at adults Total no. of cases: 776

31 CD4 values in new cases diagnosed in adults Male Female Total no. of cases: 550 Total no. of cases: 226

32 CD4 values in new HIV/AIDS cases at adults Total no. of new cases: 776

33 CD4 values in new HIV/AIDS cases at adults Male Female Total no. of cases: 550 Total no. of cases : 226

34 CD4 values in i.v. drug users vs. HIV/AIDS patients with different routes of transmission, 2013 IDUs Patients with different routes of HIV transmission

35 CD4 values in IDUs diagnosed with HIV/AIDS in 2013

36 CD4 values in IDUs vs. patients with different routes of HIV transmission, diagnosed in 2013 IDU Patients with different routes of transmission

37 CD4 values in IDUs diagnosed with HIV/AIDS in 2013

38 Viral load (VL) values for 2013 Total no. of cases in adults: 776 2% 3% 11% 11% 56% 6% 11% < > Under assessment Not assessed Sursa: Compartimentul pentru Monitorizarea şi Evaluarea Infecţiei HIV/SIDA în România INBI Prof.Dr.M.Balş

39 Viral load values in new cases at adults, diagnosed in 2013 Male Female Total no. of assessed cases: 174 Total no. of assessed cases: 89

40 Evolution of HIV/AIDS infection in Romania

41 AIDS incidence in adults and children ( ) Children 2013: 0,28/ Adults 2013: 1,74/

42 Distribution of AIDS cases by sex at 31 December 2013 (cumulative total )

43 Age groups and sex distribution of AIDS cases at 31 December 2013 (cumulative total )

44 Probable route of transmission in children with AIDS (0-14 years at date of diagnosis) 31 December 2013 (cumulative total ) *Persons who received blood transfusions at the end of the 1980s and beginning of 1990s. **Persons with repeated and/or parenteral treatments and admissions at the end 1980s and beginning of 1990s

45 Probable routes of transmission in adults diagnosed with AIDS (>14 years at date of diagnoses) at 31 December 2013 (cumulative total ) * Persons who received blood transfusions at the end of the 1980s and beginning of 1990s.

46 Distribution of AIDS cases in women, by age groups and year of diagnosis, between

47 HIV incidence in adults and children, ( ) Children 2013: 0,37/ Adults 2013: 2,54/

48 Distribution of HIV cases by sex at 31 December 2013 (cumulative total )

49 Distribution of HIV cases by sex and age groups (at date of diagnosis) at 31 December 2013 (cumulative total)

50 Probable route of transmission in children with HIV (0-14 years at date of diagnosis) at 31 December 2013 (cumulative total) *Persons who received blood transfusions at the end of the 1980s and beginning of 1990s. **Persons with repeated and/or parenteral treatments and admissions at the end 1980s and beginning of 1990s

51 Probable route of transmission in adults with HIV (>14 years at date of diagnosis) at 31 December 2013 (cumulative total) * Persons who received blood transfusions at the end of the 1980s and beginning of 1990s

52 Distribution of HIV cases in women, by year of dagnosis and age groups ( )

53 Distribution of PLWHA by age group and sex at 31 December 2013 (cumulative total ) Age group Male SEX Female TOTAL < 1 year yrs yrs yrs yrs yrs yrs yrs yrs yrs yrs yrs yrs and > TOTAL

54 HBV, HCV and HBC+HCV infections in children HIV

55 HBV, HCV and HBC+HCV infections in HIV+ adults No. cases Year of diagn. 0 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 13 VHB VHC VHB+VHC

56 AIDS defining illnesses 2013

57 Distribution of deaths cases by years

58 Mean period of survival (months) of PLWA, between BI-therapy Triple therapy

59 Mother to child transmission in Romania

60 HIV/AIDS in children with mother to child transmission

61 HIV/AIDS acquired through vertical transmission by age groups

62 Children 0-14 years: number of therapeutic regimens, prior to the current one: 31 December 2013

63 ARV schemes in children- 31 December 2013

64 Viral load in children under antiretroviral treatment

65 MTCT prophylaxis in pregnant women Total no. pregnant women Prophylaxis No prophylaxis

66 Prophylaxis of mother to child transmission in children to HIV positive mothers Year Number of newborns Number of prophylaxis

67 HIV testing 2013

68 *Data are sent by County Public Health Authorities HIV testing* in risk groups 2013 Risk groups Negative tests Positive tests TOTAL %positive STI ,71 TBC ,81 Maternity testing ,45 Pregnant women ,10 Health professionals ,00 Persons with hemodialysis ,00 Persons with transfusions ,00 Prenuptial check-up ,00 IDU ,75 Inmates ,47 MSM ,04 SWs ,86 HIV contacts ,24 Sailors ,02 Drivers ,17 Work abroad > 6 months ,58 Stay abroad > 6 months ,00 On request ,99 Occasional ,19 TOTAL ,74

69 HIV testing in pregnant women*, by age groups 2013 Age group Negative tests Positive tests TOTAL years years years years years years > 40 years Unspecified age TOTAL *Data are sent by County Public Health Authorities

70 HIV testing in pregnant women by age groups 2013

71 Total testing HIV testing in pregnant women Total testing Year

72 HIV testing in blood donors Year

73 HIV testing in STI patients Total tests Positive tests Year '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 '13 Total tests Positive tests Total tests Positive tests

74 HIV testing in TB patients Total tests Positive tests 2000 Year 0 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 ' Total tests Positive tests

75 HIV testing in HIV contacts Total tests Positive tests Year 0 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 '13 0 Total tests Positive tests

76 Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş HIV testing on request Year

77 Challenges

78 Challenges of HIV/AIDS management in Romania Impact of therapeutic fatigue on adherence to antiretroviral therapy. Advanced stage of diseases+ virologic and immunologic failure. Multiple associated diseases that require specific treatment and antiretroviral treatment. Management: ART in TB/HIV co-infection ART în HIV, HBV/HCV co-infection New HIV-IDU cases (78% HC co-infection, 12% HBV-HCV coinfection, 14% STDs in 2013) Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş

79 *National HIV/AIDS Strategy Challenges of HIV/AIDS management in Romania Most WLHA are long term survivors, infected at the end of the 1980s: Multiple therapeutic regimens- impact on ART resistance. ~50% of couples are serodiscordant (>50% women are HIV+). In this context, during the last few years the rate of MTCT has maintained a low value- <5%, due to the National Prevention Program of Mother to Child Transmission, established in In 2013 the rate represented 2,64% of the new reported cases. Further efforts are made to keep MTCT rate at low values.

80 Challenges of HIV/AIDS management in Romania During the last few years the main route of transmission has been heterosexual contact (unprotected)> in ,58% of the new cases. IDU/HIV increased: from 3% in 2010 to 329,23% in MSM/HIV has the same value: 11% of the new cases in The largest number of newly diagnosed cases has been recorded for the age group, 35% of these being late presenters. Increase in the number PLWHA whose state requires specialized medical care. Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş

81 Challenges: 2013 PLWHA MTCT ART Use IDUs Young by age, old by treatment Therapeutic fatigue Young mothers, multi- experienced in ART Mothers with unknown HIV status- tested and treated for HIV Treatment as prevention Legal drugs Source : A. Streinu-Cercel. cnlas.ro: Specific Challenges of the Hiv Epidemic in Romania. EACS 2013.

82 cohort The largest cohort in Europe age group. It represents ~half of the HIV+ population in Romania Share by sexes: 1:1 F1 subtype: approximatively 100 % Long term survivors (~6000 survivors) Multiple ART regimens (10-15!) Salvage therapy ARV toxicity therapeutic fatigue They have/want children: problemes vertical transmission Long term teratogenic effects of ART Sourse: A. Streinu-Cercel. cnlas.ro: Specific Challenges of the Hiv Epidemic in Romania. EACS 2013.

83 New cases: Late presenters: heterosexual persons, F1 subtype Real time presenters: MSM&IDUs (primary HIV infection!): MSMs: high level of education voluntary and pro-active IDUs: socially integrated tested by the healthcare professionals in the system Transmitted resistance: low levels in all groups <10% (4.6%) An important problem: children to mothers who inject drugs, which represents a risk of HIV+HCV+HBV co-infections! Source : A. Streinu-Cercel. cnlas.ro: Specific Challenges of the Hiv Epidemic in Romania. EACS 2013.

84 HIV/AIDS infection in the world 2012

85 General data on HIV/AIDS in the world December 2012 Source: UNAIDS Global Report Epidemiology September 2013 Total 35,3 million (32,2 38,8 million) PLWHA Persons infected with HIV in 2012 Adults Women Children < 15 years Total Adults 32,1 million (29,1 35,3 million) 17,7 million (16,4 19,3 million) 3,3 million (3,0 3,7 million) 2,3 million (1,9 3,7 million) 2,0 million (1,7 2,4 million) Children < 15 years ( ) AIDS deaths in 2012 Total Adults 1,6 million(1,4 1,9 million) 1,4 million (1,2 1,7 million) Children < 15 ani ( )

86 million Source: UNAIDS Global Report Epidemiology September 2013 Estimates on the numbers of PLWHA

87 Source: UNAIDS Global Report Epidemiology September 2013 Global estimates for adults and children December 2012 PLWH: 35,3 million (32,2 38,8 million) New cases of HIV cases in ,3 million (1,9 3,7 million) Deaths caused by AIDS in ,6 million (1,4 1,9 million)

88 Estimates on the number of living children and adults with HIV infection at the end of 2012 Source: UNAIDS Global Report Epidemiology September 2013

89 Estimates on the number of adults and children infected with HIV in 2012 Suource: UNAIDS Global Report Epidemiology September 2013

90 Estimates on the number of deaths caused by AIDS (adults and children) in 2012 Source: UNAIDS Global Report Epidemiology September 2013

91 Source: UNAIDS Global Report Epidemiology September 2013 Approximately 6300 persons have been infected with HIV, daily in 2012 Over 95% come from poor and developing countries. Almost 400 are children, with ages <15 years. Almost 5500 are persons between years, of whom: ~47% are women ~39% are between years

92 Source: UNAIDS Global Report Epidemiology September 2013 Global estimates on HIV and AIDS at the end of 2012 Children (<15 years) Children LWHA 3,3 million (3,1 3,8 million) Newly infected children in ( ) Deaths caused by AIDS in ( )

93 Source: UNAIDS Global Report Epidemiology September 2013 Statistical data by regions December 2012

94 HIV/AIDS estimates within the WHO Region (53 countries) Reported cases of HIV/AIDS (cumulative total): AIDS cases: AIDS deaths: HIV infection: Source: HIV surveillance Report 2012

95 Characteristics of HIV cases, diagnosed in the WHO European Region, by geographical areas WHO European Region West Centre East EU/EEA Countries Reporting countries/number 51/53 23/23 15/15 13/15 30/31 Number of HIV cases Rate/ population 7,8 6,6 1,9 22 5,8 % of cases: age group 10,3% 9,8% 15,4% 10,1% 10,6% Men/women ratio 2,1 3,1 4,5 1,4 3,2 Route of transmission Heterosexual 45,6% 35,3% 24,6% 60,2% 33,8% MSM 22,8% 41,7% 26,3% 1,2% 40,4% IV Drugs 17,8% 5,1% 7,4% 33,6% 6,1% Unknown 12,3% 17% 36,9% 3,2% 18,7% No data: Liechtenstein, Rusisa şand Uzbekistan; Countries that did not report age groups and routes of transmission are excluded *includes persons(12%) coming from Sub-Saharan African Countries; Source: HIV/AIDS surveillance Report 2012

96 Case definition: CDC&ECDC Stockholm This section contains the case definitions* for Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection *Source: Commission Decision of 28/IV/2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council Clinical Criteria (AIDS) Any person who has any of the clinical conditions as defined in the European AIDS case definition for: Adults and adolescents > 13 years [1] Children < 13 years of age [2] Laboratory Criteria (HIV) Adults, adolescents and children aged = 18 months At least one of the following three: Positive result of a HIV screening antibody test or a combined screening test (HIV antibody and HIV p24 antigen) confirmed by a more specific antibody test (e.g. Western blot) Positive result of 2 EIA antibody test confirmed by a positive result of a further EIA test Positive results on two separate specimens from at least one of the following three: Detection of HIV nucleic acid (HIV-RNA, HIV-DNA) Demonstration of HIV by HIV p24 antigen test, including neutralisation assay Isolation of HIV

97 Children aged <18 months Positive results on two separate specimens (excluding cord blood) from at least one of the following three: Isolation of HIV Detection of HIV nucleic acid (HIV-RNA, HIV-DNA) Demonstration of HIV by HIV p24 antigen test, including neutralisation assay in a child =1 month of age Epidemiological Criteria NA Case Classification A. Possible case NA B. Probable case NA C. Confirmed case HIV infection Any person meeting the laboratory criteria for HIV infection AIDS Any person meeting the clinical criteria for AIDS and the laboratory criteria for HIV infection

98 Definitions Incidence = number of new cases x /population, registered at 1 July Prevalence = number of new and old cases x /population registered at 1 July Child = individual entering the 0-14 age group, according to CDC definition ( ). Adult = individual over 15 years, according to CDC definition ( ).

99 *Sources Revised surveillance Case Definition for HIV Infection Among Adults, Adolescents, and Children Aged < 18 Month sand for HIV Infection and AIDS Among Children Aged 18 Months to <13 years--- CDC, United States, Commission Decision of 28/IV/2008 amending Decision 2002/253/Ec laying down case definitions for reporting communicable diseases to the Community network under Decision no 2119/98/EC of the European Parliament and Council Who case definitions of HIV for surveillance and Revised clinical staging and immunological Classification of HIV-related disease in adults and Children (World Health Organization 2007)

100 Manager: Prof.Dr. Adrian Streinu-Cercel Head of Infectious Diseases UMF Carol Davila President of National Committee to Fight AIDS& Infectious Diseases Committee Coordinator: Coordinator Adults Programme: CoordInator Children Programme: Mariana Mărdărescu MD PhD Lecturer Dr.Elisabeta Otilia Benea Dr. Sorin Petrea Statistical data operators : PC Operators: Epidemiology: As.med. Marieta Iancu Daniela Viţelaru Sanda Vintilă Dr. Ionel Iosif

The evolution of HIV/AIDS infection in Romania 31 December 2017

The evolution of HIV/AIDS infection in Romania 31 December 2017 The evolution of HIV/AIDS infection in Romania 31 December 2017 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS

More information

HIV/AIDS infection in Romania 30 June 2018

HIV/AIDS infection in Romania 30 June 2018 HIV/AIDS infection in Romania 30 June 2018 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS Data and further processed

More information

Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion

Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion Mariana Mărdărescu MD PhD Adrian Streinu-Cercel MD PhD HC Mike Youle MD PhD

More information

ROMANIA. HIV/AIDS statistical data 30 June 2013

ROMANIA. HIV/AIDS statistical data 30 June 2013 ROMANIA HIV/AIDS statistical data 30 June 2013 The following information are the synthesis of a collecting process based on HIV/AIDS charts, delivered by nine Regional HIV Centers and Compartment for Monitoring

More information

STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA

STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA Simona Claudia CAMBREA MD, Ph D Faculty of Medicine, Ovidius University, Constanta, Romania Clinical Infectious

More information

30 years of HIV experience in Romania

30 years of HIV experience in Romania 30 years of HIV experience in Romania UNAIDS objectives Source: http://www.unaids.org/sites/default/files/media_asset/jc2686_wad2014report_en.pdf Europe 2013 Geographical/epidemiological division of the

More information

HIV and Paediatrics in Central Europe

HIV and Paediatrics in Central Europe 2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV HIV and Paediatrics in Central Europe Mariana Mărdărescu MD PhD Consultant in Infectious Diseases Senior Doctor in

More information

HIV infection in children. Mariana Mardarescu MD PhD,

HIV infection in children. Mariana Mardarescu MD PhD, HIV infection in children Mariana Mardarescu MD PhD, Paediatric and Adolescents Immunodepression Department National Institute for Infectious Diseases Prof. Dr. Matei Bals, Bucharest A child is not a miniature

More information

Hepatitis C Burden in Romania Evaluation 2018 Challenges Prof. Adrian Streinu-Cercel MD, PhD, HC

Hepatitis C Burden in Romania Evaluation 2018 Challenges Prof. Adrian Streinu-Cercel MD, PhD, HC Hepatitis C Burden in Romania 2016-2017 Evaluation 2018 Challenges Prof. Adrian Streinu-Cercel MD, PhD, HC Carol Davila University of Medicine and Pharmacy National Institute For Infectious Diseases, Prof.

More information

Module 1: HIV epidemiology, transmission and prevention

Module 1: HIV epidemiology, transmission and prevention Session 1 Module goals Module 1 Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches

More information

Scaling up priority HIV/AIDS interventions in the health sector

Scaling up priority HIV/AIDS interventions in the health sector TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June

More information

EDMA HIV-AIDS TEAM Fact Sheet November 2007

EDMA HIV-AIDS TEAM Fact Sheet November 2007 EDMA HIV-AIDS TEAM Fact Sheet November 2007 1. HIV Facts AIDS epidemic update UNAIDS Epidemic Update, November 2007 (1) 760,000 people to be living with HIV in Western and Central Europe in 2007. 31,000

More information

Program to control HIV/AIDS

Program to control HIV/AIDS 90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,

More information

HIV-HBV coinfection in HIV population horizontally infected in early childhood between

HIV-HBV coinfection in HIV population horizontally infected in early childhood between UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE HIV-HBV coinfection in HIV population horizontally infected in early childhood between 1987-1990 Supervising professor: Prof. Cupşa Augustin

More information

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.

More information

ROMANIA. Country Progress Report on AIDS Reporting period January 2014 December 2014

ROMANIA. Country Progress Report on AIDS Reporting period January 2014 December 2014 ROMANIA Country Progress Report on AIDS Reporting period January 2014 December 2014 Bucharest, 2015 1 Contents Abbreviations... 3 I. Status at a glance... 4 a) Inclusiveness of stakeholders in the report-writing

More information

HIV-1 Subtypes Circulating in Constanta

HIV-1 Subtypes Circulating in Constanta ARS Medica Tomitana - 2017; 4(23): 163-169 10.1515/arsm-2017-0030 Cernat Roxana-Carmen1, Dumitru Irina Magdalena1, 2, Oțelea D.3, Rugină S. 1,2,4,5 HIV-1 Subtypes Circulating in Constanta 1 Clinical Hospital

More information

Annual Epidemiological Report

Annual Epidemiological Report November 2018 Annual Epidemiological Report 1 HIV in Ireland, 2017 Key Facts There were 492 diagnoses of HIV notified in 2017, a rate of 10.3 per 100,000 population. The HIV rate in Ireland has been relatively

More information

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 1 Objectives of today s lecture Describe global goals in the fight against HIV Review the epidemiology

More information

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C4 - Health determinants Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012,

More information

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State

More information

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a

More information

ECDC s role in the fight against HIV/AIDS in Europe

ECDC s role in the fight against HIV/AIDS in Europe European Centre for Disease Prevention and Control ECDC s role in the fight against HIV/AIDS in Europe Marita van de Laar, PhD Program Coordinator HIV/AIDS, STI, hepatitis HIV in Europe, Stockholm, 2 November

More information

Towards universal access

Towards universal access Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

More information

GLOBAL AIDS MONITORING REPORT

GLOBAL AIDS MONITORING REPORT KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017

More information

Key issues for HIV testing and

Key issues for HIV testing and Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics

More information

ECDC and Spanish Ministry of Health workshop:

ECDC and Spanish Ministry of Health workshop: ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,

More information

Treat All : From Policy to Action - What will it take?

Treat All : From Policy to Action - What will it take? Strategy Finance Integration Cascade of services People centred Political Will Treat All : From Policy to Action - What will it take? Thursday, 9 June, 13.00 14.30 Conference Room 11, United Nations Questions

More information

The evolution of the HIV/AIDS outbreak among IDUs in Romania

The evolution of the HIV/AIDS outbreak among IDUs in Romania The evolution of the HIV/AIDS outbreak among IDUs in Romania Romanian National Antidrug Agency Romanian National Focal Point on Drugs Andrei Botescu * Lisbon, 12 th October 2012 HIV outbreak among IDU

More information

Screening programmes for Hepatitis B/C in Europe

Screening programmes for Hepatitis B/C in Europe Programme STI, HIV/AIDS and viral hepatitis Screening programmes for Hepatitis B/C in Europe Mika Salminen, Ph.D. European Centre for Disease Prevention and Control Why might screening be needed for hepatitis

More information

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County PREVENTION OF HIV IN THE TIMES OF PREP Daniela Chiriboga, MD Florida Department of Health in Polk County MAKING THE CASE FOR PREVENTION The Epidemic in Florida Population in 2014: 19.6 million (3 rd in

More information

AIDS was described in June 1981 among homosexuals in the USA, and the virus. HIV/AIDS epidemic features and trends in Saudi Arabia

AIDS was described in June 1981 among homosexuals in the USA, and the virus. HIV/AIDS epidemic features and trends in Saudi Arabia ORIGINAL ARTICLE HIV/AIDS epidemic features and trends in Saudi Arabia Yagob Y. Al-Mazrou, PhD, FRCGP; Mohamed H. Al-Jeffri, MSc, DTM&H; Abdulla Ibrahim Fidail, DPH, MPH; Nasir Al-Huzaim, MPH, PhD; Sirrag

More information

AIDS Acquired Immune Deficiency Syndrom

AIDS Acquired Immune Deficiency Syndrom HIV and AIDS World, Europe and Poland Dorota Chrominska-Szosland MD, PhD Nofer Institute of Occupational Medicine Lodz-Poland HIV Human Immunodeficiency Virus AIDS Acquired Immune Deficiency Syndrom 1

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute

More information

HIV Lecture. Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital

HIV Lecture. Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital HIV Lecture Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital End-2001 global estimates for children and adults People living with HIV/AIDS New HIV infections in

More information

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Viral Hepatitis Burden and Policy Directions in the European Region of WHO Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all

More information

ECDC update to the EU Commission Think Tank on HIV/AIDS

ECDC update to the EU Commission Think Tank on HIV/AIDS ECDC update to the EU Commission Think Tank on HIV/AIDS Andrew Amato Head of HIV, STI and V. Hepatitis programme, ECDC Luxembourg, 10-11 December 2013 Outline Main ECDC reports published since last Think

More information

Tunisian recommendations on ART : process and results

Tunisian recommendations on ART : process and results Second Arab Congress of Clinical Microbiology and Infectious Diseases May 24-26, 2012. Tunisian recommendations on ART : process and results M. BEN MAMOU UNAIDS Email: BenmamouM@unaids.org M. CHAKROUN

More information

Monitoring Recent HIV Infection in Ireland, 2017

Monitoring Recent HIV Infection in Ireland, 2017 Monitoring Recent HIV Infection in Ireland, 2017 January 2019 Key Facts 1 13% of HIV diagnoses in 2017 (of those tested) were likely to be recent infections (within 4 months), using the Recent Infection

More information

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006 Mid-term Review of the UNGASS Declaration of Commitment on HIV/AIDS Ireland 2006 Irish Role in Global Response Just as the HIV/AIDS epidemic is a global threat, addressing the challenge of the epidemic

More information

HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE

HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE THE REMAINING CHALLENGES DR YOGAN PILLAY, NDOH SA HIV CLINICIANS SOCIETY CONFERENCE, CAPE TOWN 25 NOVEMBER, 2012 GLOBAL DATA 34m people living with

More information

HIV Testing. ECHO Hep C. Judith Feinberg, MD June 22, 2017

HIV Testing. ECHO Hep C. Judith Feinberg, MD June 22, 2017 HIV Testing ECHO Hep C Judith Feinberg, MD June 22, 2017 Overview A few basics HIV epidemiology in the US HIV testing Time course of HIV-1 infection symptoms HIV proviral DNA symptoms window period HIV

More information

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

Sex Work in Sub-Saharan Africa : Opportunities and Challenges Sex Work in Sub-Saharan Africa : Opportunities and Challenges Dr Traore Isidore May 26, 2016 Definition of Sex Worker Female, male and transgender adults (18 years of age and above) who receive money or

More information

Linkages between Sexual and Reproductive Health and HIV

Linkages between Sexual and Reproductive Health and HIV Linkages between Sexual and Reproductive Health and HIV Manjula Lusti-Narasimhan Department of Reproductive Health and Research World Health Organization The HIV pandemic 25 years 1981 2006 Rationale for

More information

Outline. AIDS & HIV in the Travis County. Global estimates for adults & children end HIV incidence worldwide

Outline. AIDS & HIV in the Travis County. Global estimates for adults & children end HIV incidence worldwide Outline AIDS & HIV in the Joshua Vest Epidemiologist Austin/ Health & Human Services Department Worldwide HIV/AIDS surveillance National Prevalence Trends Disparities Mortality Modes of exposure Risk factors

More information

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London When PrEP fails Laura Waters MD FRCP Mortimer Market Centre London www.aidsunited.org PrEP works If people at risk take it If it s taken in the right way If it s available Commissioned/licensed Affordable

More information

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University November 5, 2016 None HIV epidemiology Global U.S. Washington, D.C.

More information

HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016

HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016 HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016 1 Thus the HIV DR needs to focus on prevention and then diagnostic capacity to 1 st provide VL monitoring for early &

More information

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD 17 May 2018 Bucharest, Romania Organisers Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe

More information

HIV AND HEPATITIS B/C CO-INFECTION IN KWAZULU-NATAL FROM 2002 TO 2010: A RETROSPECTIVE DATABASE ANALYSIS

HIV AND HEPATITIS B/C CO-INFECTION IN KWAZULU-NATAL FROM 2002 TO 2010: A RETROSPECTIVE DATABASE ANALYSIS HIV AND HEPATITIS B/C CO-INFECTION IN KWAZULU-NATAL FROM 2002 TO 2010: A RETROSPECTIVE DATABASE ANALYSIS Submitted to: SCHOOL OF NURSING AND PUBLIC HEALTH UNIVERSITY OF KWAZULU-NATAL DURBAN SOUTH AFRICA

More information

HIV AND AIDS FACT SHEETS

HIV AND AIDS FACT SHEETS The Human Immunodeficiency Virus (HIV) has been one of the most devastating new diseases to emerge over the course of the past century. Even though HIV may not always be in the headlines now, it is still

More information

Improving accessibility to antiretroviral drugs: A south-south collaboration

Improving accessibility to antiretroviral drugs: A south-south collaboration Improving accessibility to antiretroviral drugs: A south-south collaboration Jaideep A Gogtay MD Cipla Ltd Mumbai jgogtay@cipla.com Adults and children estimated to be living with HIV at the end of 2000

More information

Epidemiological Characteristics of HIV/AIDS Pandemic in Romania

Epidemiological Characteristics of HIV/AIDS Pandemic in Romania [ Applied Medical Informatics Original Research Vol. 27, No. 4/2010, pp: 31-38 Epidemiological Characteristics of HIV/AIDS Pandemic in Corina-Liana MANIU *, Andrei ACHIMAŞ CADARIU Iuliu Haţieganu University

More information

Roche to provide HIV diagnostic solutions to Global Fund. Framework agreement with Global Fund strengthens access to HIV diagnostics

Roche to provide HIV diagnostic solutions to Global Fund. Framework agreement with Global Fund strengthens access to HIV diagnostics Media Release June 18, 2015 Roche to provide HIV diagnostic solutions to Global Fund Framework agreement with Global Fund strengthens access to HIV diagnostics Roche (SIX: RO, ROG; OTCQX: RHHBY) announced

More information

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National

More information

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department.

More information

Okinawa, Toyako, and Beyond: Progress on Health and Development

Okinawa, Toyako, and Beyond: Progress on Health and Development Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,

More information

Fertility Desires/Management of Serodiscordant HIV + Couples

Fertility Desires/Management of Serodiscordant HIV + Couples Fertility Desires/Management of Serodiscordant HIV + Couples William R. Short, MD, MPH Assistant Professor of Medicine Division Of Infectious Diseases Jefferson Medical College of Thomas Jefferson University

More information

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Version for the Silent Procedure 29 April Agenda item January Hepatitis Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh

More information

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38 2016 Annual Morbidity Report HEPATITIS C, ACUTE a Rates calculated based on less than 19 cases or events are considered unreliable b Calculated from: CDC. Notice to Readers: Final 2016 Reports of Nationally

More information

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per

More information

Viral Hepatitis in Ireland, 2005

Viral Hepatitis in Ireland, 2005 Viral Hepatitis in Ireland, 25 Key Points Hepatitis A incidence remained low, with 56 cases notified in 25 The number of hepatitis B notifications continued to increase with 95 cases reported in 25, compared

More information

The outlook for hundreds of thousands adolescents is bleak.

The outlook for hundreds of thousands adolescents is bleak. Adolescents & AIDS Dr. Chewe Luo Chief HIV/AIDS, UNICEF Associate Director, Programmes Division 28/11/17 Professor Father Micheal Kelly Annual Lecture on HIV/AIDS Dublin, Ireland The outlook for hundreds

More information

Clinical and Public Health Policy Implications of Findings that:

Clinical and Public Health Policy Implications of Findings that: Clinical and Public Health Policy Implications of Findings that: Adherence to HIV Medications and Emotional/Physiological Coping with Stress are Independently Associated with Specific Five-Year Outcome

More information

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child

More information

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology HIV stands for human immunodeficiency virus. If left untreated, HIV can lead to the disease AIDS (acquired immunodeficiency syndrome).

More information

HIV/AIDS Epidemiology in Alameda County: State of the County Report

HIV/AIDS Epidemiology in Alameda County: State of the County Report Lake Merritt, Oakland,California HIV/AIDS Epidemiology in Alameda County: State of the County Report Muntu Davis, MD, MPH County Health Officer and Public Health Director Alameda County White House Office

More information

STI and HIV Prevention and Care among Sex Workers

STI and HIV Prevention and Care among Sex Workers Training Course in Sexual and Reproductive Health Research 2017 Module: Sexually transmitted infections, HIV/AIDS STI and HIV Prevention and Care among Sex Workers Annette Verster and Michelle Rodolph

More information

STD & HIV ANNUAL REPORT. An Annual Review of HIV and STD s reported in Oakland County, Michigan

STD & HIV ANNUAL REPORT. An Annual Review of HIV and STD s reported in Oakland County, Michigan STD & HIV ANNUAL REPORT 2016 An Annual Review of HIV and STD s reported in Oakland County, Michigan Similar to numbers reported statewide, Oakland County saw an increase in the number of reported cases

More information

IFMSA Policy Statement Ending AIDS by 2030

IFMSA Policy Statement Ending AIDS by 2030 IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled

More information

Integration of collaborative TB/HIV activities with harm reduction services

Integration of collaborative TB/HIV activities with harm reduction services Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases control, Head of Department on HIV/AIDS combating

More information

Assessment of G8 Commitments on Maternal, Newborn and Child Health

Assessment of G8 Commitments on Maternal, Newborn and Child Health Assessment of G8 Commitments on Maternal, Newborn and Child Health Robin Lennox Researcher, G8 Research Group June 13, 2010 In January 2010, Canadian prime minister Stephen Harper announced that maternal,

More information

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness

More information

Concept note. 1. Background and rationale

Concept note. 1. Background and rationale Concept note Inter-Country Workshops for Strengthening Regional and National Human Capacity to Accelerate Scaling up of National PMTCT and Paediatric Care, Support and Treatment Programmes TOWARDS UNIVERSAL

More information

Missouri St. Louis TGA 2016 HIV Epidemiological Profile

Missouri St. Louis TGA 2016 HIV Epidemiological Profile Missouri St. Louis TGA 2016 HIV Epidemiological Profile St. Louis TGA Part A Planning Council Prepared by the City of St. Louis Department of Health Center for Health Information, Research, and Planning

More information

HIV/AIDS MODULE. Rationale

HIV/AIDS MODULE. Rationale HIV/AIDS MODULE Rationale According to WHO HIV/AIDS remains one of the world's most significant public health challenges, particularly in low- and middle-income countries. As a result of recent advances

More information

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018 South Africa s National HIV Programme Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH 23 October 2018 Overview The HIV and AIDS sub-programme at NDOH is responsible for: policy formulation, coordination,

More information

Progress against the HIV Epidemic: is the end in sight?

Progress against the HIV Epidemic: is the end in sight? Progress against the HIV Epidemic: is the end in sight? Christine Hughes, BscPharm, PharmD, FCSHP Professor, Faculty of Pharmacy & Pharmaceutical Sciences University of Alberta Clinical Pharmacist, Northern

More information

Government of Canada Federal AIDS Initiative Milestones

Government of Canada Federal AIDS Initiative Milestones HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for

More information

HIV/Hepatitis co-infection situation in Romania. Oana Săndulescu, MD, PhD

HIV/Hepatitis co-infection situation in Romania. Oana Săndulescu, MD, PhD HIV/Hepatitis co-infection situation in Oana Săndulescu, MD, PhD Carol Davila University of Medicine and Pharmacy National Institute of Infectious Diseases Prof. Dr. Matei Balș Bucharest, Disclosures Carol

More information

Mariza Vono Tancredi. Eliseu Alves Waldman

Mariza Vono Tancredi. Eliseu Alves Waldman Mariza Vono Tancredi Eliseu Alves Waldman RATIONALE The clinical and laboratorial data from a population at a STD/AIDS Referral and Training Center (CRT) in Sao Paulo, Brazil, with 7,853 HIV infected individuals

More information

Human Immunodeficiency Virus

Human Immunodeficiency Virus Human Immunodeficiency Virus Isolated in 1983 by Luc Montagnier & Robert Gallo, separately. Genetic material is RNA Carries reverse transcriptase, an enzyme that makes DNA out of RNA in the host cell Cells

More information

TOWARDS UNIVERSAL ACCESS

TOWARDS UNIVERSAL ACCESS At a glance TOWARDS UNIVERSAL ACCESS Scaling up priority HIV/AIDS interventions in the health sector June 2008 Progress Report This document represents material excerpted from Towards universal access:

More information

15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy

15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy 15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy Lecturer Ana Maria TudorMD PhD * Mariana Mărdărescu MD PhD * Professor Ioana Anca MD PhD * * National Institute for Infectious

More information

Hepatitis C. Core slides

Hepatitis C. Core slides Hepatitis C Core slides This material was prepared by the Viral Hepatitis Prevention Board The slides (or subsets) can be reproduced for educational use only, with reference to the original source and

More information

Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China

Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China China presentation Wang Linhong MD, Professor National Center of MCH, China CDC 1 HIV/AIDS

More information

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution

More information

Integration of recent infection monitoring into national HIV surveillance: 2016 results January 2018

Integration of recent infection monitoring into national HIV surveillance: 2016 results January 2018 Integration of recent infection monitoring into national HIV surveillance: 2016 results January 2018 Key Points In this pilot study, 13% of HIV diagnoses in 2016 were likely to be recent infections (within

More information

HIV/AIDS in China. -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA

HIV/AIDS in China. -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA HIV/AIDS in China -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA September 12, 2008 1 HIV epidemic in Asia General Population

More information

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP HIV: Pregnancy in Serodiscordant Couple Dr Chow TS ID Clinic HPP Sexual Reproductive Health and Rights The recognition of the sexual and reproductive health and rights (SRHR) of all individuals and couples

More information

HIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED

HIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED HIV and PEP LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED Disclaimer The views expressed in this presentation are those of the speaker and do not reflect the official policy of the Department

More information

Metro St. Louis HIV Epidemiological Profile

Metro St. Louis HIV Epidemiological Profile Metro St. Louis HIV Epidemiological Profile Saint Louis TGA Part A Planning Council Prepared by the City of St. Louis Department of Health s Center for Health Information, Research, and Planning Table

More information

The effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors

The effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors The effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors Aura Temereanca 1,2, Luminita Ene 3, Adelina Rosca

More information

Harm reduction among drug users in Spain

Harm reduction among drug users in Spain Harm reduction among drug users in Spain Luxemburg,, 27 October 21 Dr. José Manuel Arroyo Cobo Deputy Director General of Health in Prisons Ministry of Internal Affairs Dr. Tomás s Hernández ndez Fernández

More information

HIV in Ireland 2016 Report

HIV in Ireland 2016 Report HIV in Ireland 2016 Report Acknowledgements In order to accurately track the HIV epidemic in Ireland and to assess the impact of HIV prevention programmes, it is essential to have good quality surveillance

More information

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( ) Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies

More information

Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions

Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions Harvard-Brazil Collaborative Public Health Field Course January 2014 Lecture # 8 Building specialized knowledge: HIV Aluisio Segurado Department of Infectious Diseases School of Medicine, University of

More information

2004 Update. Luxembourg

2004 Update. Luxembourg 2004 Update Luxembourg 2 Luxembourg HIV/AIDS estimates In 2003 and during the first quarter of 2004, UNAIDS and WHO worked closely with national governments and research institutions to recalculate current

More information

AN EVALUATION OF HIV CASE-BASED SURVEILLANCE IN IRELAND: DESCRIPTION OF THE SYSTEM, SENSITIVITY AND TIMELINESS. November 2015

AN EVALUATION OF HIV CASE-BASED SURVEILLANCE IN IRELAND: DESCRIPTION OF THE SYSTEM, SENSITIVITY AND TIMELINESS. November 2015 AN EVALUATION OF HIV CASE-BASED SURVEILLANCE IN IRELAND: DESCRIPTION OF THE SYSTEM, SENSITIVITY AND TIMELINESS November 2015 Authors: Coralie Giese, European Program for Intervention Epidemiology Training,

More information

State of Alabama HIV Surveillance 2013 Annual Report Finalized

State of Alabama HIV Surveillance 2013 Annual Report Finalized State of Alabama HIV Surveillance 2013 Annual Report Finalized Prepared by: Division of STD Prevention and Control HIV Surveillance Branch Contact Person: Allison R. Smith, MPH Allison.Smith@adph.state.al.us

More information